Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY was delisted on the 10th of August, 2023.
89 hedge funds and large institutions have $232M invested in Chinook Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 19 closing their positions.
184% more call options, than puts
Call options by funds: $2.48M | Put options by funds: $875K
180% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 15
11% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 19
2% more funds holding
Funds holding: 87 → 89 (+2)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
55% less capital invested
Capital invested by funds: $520M → $232M (-$288M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
+$5.58M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$3.72M |
| 3 |
SAM
Senzar Asset Management
New York
|
+$3.46M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.21M |
| 5 |
SIM
Spark Investment Management
New York
|
+$1.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.89M |
| 2 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
-$9.85M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$9.74M |
| 4 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$5.4M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$2.97M |
KDNY Hedge Fund Activity: Q1 2016 in Review
89 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q1 2016, worth a combined $232M — down 55% from $520M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new KDNY positions and 19 closed out — a net gain of 2 holders — while 42 added to existing stakes and 15 trimmed.
The largest buyer was Oak Ridge Investments, adding an estimated $5.58M. The largest seller was Fidelity Investments, cutting an estimated $9.89M.
- 89 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q1 2016, up from 87 in Q4 2015.
- Funds reported $232M of Chinook Therapeutics, Inc. Common Stock stock for Q1 2016, down 55% quarter-over-quarter.
- 21 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q1 2016 and 19 closed out, a net change of +2 holders.
- The largest Chinook Therapeutics, Inc. Common Stock buyer in Q1 2016 was Oak Ridge Investments, an estimated $5.58M added.
- The largest Chinook Therapeutics, Inc. Common Stock seller in Q1 2016 was Fidelity Investments, an estimated $9.89M sold.
Based on aggregated 13F filings for Q1 2016.